475 related articles for article (PubMed ID: 36152586)
1. Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders.
Yadav S; Dwivedi A; Tripathi A; Tripathi AK
Nutr Res; 2022 Oct; 106():72-84. PubMed ID: 36152586
[TBL] [Abstract][Full Text] [Related]
2. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
Li JM; Yu R; Zhang LP; Wen SY; Wang SJ; Zhang XY; Xu Q; Kong LD
Microbiome; 2019 Jun; 7(1):98. PubMed ID: 31255176
[TBL] [Abstract][Full Text] [Related]
3. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation and replenishment of short-chain fatty acids protect against chronic cerebral hypoperfusion-induced colonic dysfunction by regulating gut microbiota, differentiation of Th17 cells, and mitochondrial energy metabolism.
Su SH; Wu YF; Lin Q; Zhang L; Wang DP; Hai J
J Neuroinflammation; 2022 Dec; 19(1):313. PubMed ID: 36567333
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review.
Rauf A; Khalil AA; Rahman UU; Khalid A; Naz S; Shariati MA; Rebezov M; Urtecho EZ; de Albuquerque RDDG; Anwar S; Alamri A; Saini RK; Rengasamy KRR
Crit Rev Food Sci Nutr; 2022; 62(22):6034-6054. PubMed ID: 33703960
[TBL] [Abstract][Full Text] [Related]
7. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.
Nogal A; Valdes AM; Menni C
Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33764858
[TBL] [Abstract][Full Text] [Related]
8. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
[TBL] [Abstract][Full Text] [Related]
9. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
10. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-derived short chain fatty acids act as mediators of the gut-brain axis targeting age-related neurodegenerative disorders: a narrative review.
Guo B; Zhang J; Zhang W; Chen F; Liu B
Crit Rev Food Sci Nutr; 2023 Oct; ():1-22. PubMed ID: 37897083
[TBL] [Abstract][Full Text] [Related]
13. Interplay of human gastrointestinal microbiota metabolites: Short-chain fatty acids and their correlation with Parkinson's disease.
Liu J; Chen Q; Su R
Medicine (Baltimore); 2024 Apr; 103(17):e37960. PubMed ID: 38669388
[TBL] [Abstract][Full Text] [Related]
14. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
Sivaprakasam S; Prasad PD; Singh N
Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
[TBL] [Abstract][Full Text] [Related]
15. Short-Chain Fatty Acids in the Microbiota-Gut-Brain Axis: Role in Neurodegenerative Disorders and Viral Infections.
Majumdar A; Siva Venkatesh IP; Basu A
ACS Chem Neurosci; 2023 Mar; 14(6):1045-1062. PubMed ID: 36868874
[TBL] [Abstract][Full Text] [Related]
16. The regulatory roles of dietary fibers on host health via gut microbiota-derived short chain fatty acids.
Xu T; Wu X; Liu J; Sun J; Wang X; Fan G; Meng X; Zhang J; Zhang Y
Curr Opin Pharmacol; 2022 Feb; 62():36-42. PubMed ID: 34896759
[TBL] [Abstract][Full Text] [Related]
17. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
Ohira H; Tsutsui W; Fujioka Y
J Atheroscler Thromb; 2017 Jul; 24(7):660-672. PubMed ID: 28552897
[TBL] [Abstract][Full Text] [Related]
18. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response.
Huang W; Zhou L; Guo H; Xu Y; Xu Y
Metabolism; 2017 Mar; 68():20-30. PubMed ID: 28183450
[TBL] [Abstract][Full Text] [Related]
19. Prebiotics and Community Composition Influence Gas Production of the Human Gut Microbiota.
Yu X; Gurry T; Nguyen LTT; Richardson HS; Alm EJ
mBio; 2020 Sep; 11(5):. PubMed ID: 32900799
[TBL] [Abstract][Full Text] [Related]
20. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
